Jacqueline Ingram is a principal member of the commercial engagement health equity team at Genentech and a member of the 91少女 Board of Directors. Jackie brings decades of experience in healthcare, financial management, and more. Prior to her current role at Genentech, Jackie managed key accounts and sales for Genentech, Admedus, and Boehringer Ingelheim. Jackie earned her BA from Yale University and her MBA from Columbia Business School.